Thompson Street Capital Partners
St. Louis, Missouri
Founded:2000
Firm Location:St. Louis, Missouri • Panama City, Florida
Thompson Street Capital Partners Team
Jeff Aiello
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B)
Craig Albrecht
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Elizabeth Borow
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B)
Rick Clifton
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Midwest (Other Lists), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B)
Joe Jedlicka
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B)
Jesse Keipp
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Midwest (Other Lists), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in FinTech (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in FinTech (Series B)
Brian Kornmann
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Midwest (Other Lists), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B)
Alison Schulte
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Midwest (Other Lists), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B)
Jack Senneff
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B)
Investors in St. Louis (MO)
Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Enterprise Applications (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Midwest (Other Lists), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Vince Warrick
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Enterprise (Series B), Investors in Midwest (Other Lists)
Investors in St. Louis (MO)
Investors in Pharmaceuticals (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Midwest (Other Lists), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B)
Kelly Wittenbrink
Sweet spot: $25.0M
Range: $5.0M - $50.0M
Investors in St. Louis (MO)
Investors in Enterprise Infrastructure (Series B), Investors in Enterprise Applications (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Enterprise Infrastructure (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Enterprise Applications (Series B), Investors in Consumer Health (Series B), Investors in Midwest (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B)